Gemmer Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Gemmer Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-50	Closed	-$4K	–	1262
2015 Q3	$4K	Buy	+50	New	+$4.89K	﹤0.01%	868
2014 Q4	–	Sell	-50	Closed	-$3K	–	1409
2014 Q3	$3K	Buy	+50	New	+$2.15K	﹤0.01%	1007

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Gemmer Asset Management's AGIO Position: Q4 2015 in Review

Gemmer Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2015, closing a stake of 50 shares — an estimated $4K sold.

Gemmer Asset Management first reported a position in AGIO in Q3 2014 and held it in 2 quarters. The position peaked at $4K in Q3 2015. 145 funds tracked by Wall St. Rank hold AGIO as of Q4 2015.

Gemmer Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Gemmer Asset Management sold 50 Agios Pharmaceuticals shares in Q4 2015, an estimated $4K.
Gemmer Asset Management first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 2 quarters.
Gemmer Asset Management's Agios Pharmaceuticals position peaked at $4K in Q3 2015.
145 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2015.

Based on Gemmer Asset Management's 13F filing for Q4 2015, filed 22 Jan 2016.